" class="no-js "lang="en-US"> Rajesh Nair - Medtech Alert
Saturday, April 04, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Rajesh Nair

Rajesh Nair

About Rajesh Nair

Related Story

News

 Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing

Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution

November 2 2021

Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been […]

News

 Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain | Pharmtech Focus

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain

September 7 2021

Local family cord blood bank Cryoviva Singapore is continuing with its rapid geographic growth plans […]